Please assess the completion status of the following clinical trial:

Trial Title: The Dutch Asymptomatic Mitral Regurgitation Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Asymptomatic~* Severe organic mitral valve regurgitation.~* Preserved left ventricular function (left ventricular ejection fraction \>60% and left ventricular end-systolic dimension ≤45 mm)~* The likelihood of MV repair should be more than 90% determined by the local heart team with a cardiologist and cardiothoracic surgeon~Exclusion Criteria:~* Pulmonary hypertension (\>50 mmHg at rest)~* Atrial fibrillation~* Physical inability as determined by the heart team to undergo surgery~* Other life-threatening morbidity~* Higher expected surgical risks in advance, according to the dedicated heart team~* Moderate to severe kidney disease (eGFR less than 30 mL/min)~* Flail leaflet together with a left ventricular end systolic diameter (LVESD) \>40 mm

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Early mitral valve repair (Type: ACTIVE_COMPARATOR): Early mitral valve repair
- Watchful waiting (Type: ACTIVE_COMPARATOR): Watchful waiting

Based on this trial design, predict the completion outcome and termination type (if applicable).